Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Finasteride effectively treats male hair loss, increasing length and thickness.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Massaging the scalp with a cosmetic containing certain natural inhibitors can significantly regrow hair in men with pattern baldness.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Hair loss and excessive growth treated with various options, including new laser technology.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.